Plasma sPD-L1 and VEGF levels are associated with the prognosis of NSCLC patients treated with combination immunotherapy
Sign Up to like & getrecommendations! Published in 2024 at "Anti-Cancer Drugs"
DOI: 10.1097/cad.0000000000001576
Abstract: The clinical significance of plasma soluble programmed cell death ligand 1 (sPD-L1) and vascular endothelial growth factor (VEGF) for non-small cell lung cancer (NSCLC) treated with the combination of anti-angiogenic therapy and anti-PD-L1 antibody (Ab)… read more here.
Keywords: spd vegf; nsclc patients; vegf levels; treated combination ... See more keywords
Granulomatous pigmented purpuric dermatosis favorably treated with the combination of colchicine and calcium dobesilate
Sign Up to like & getrecommendations! Published in 2020 at "Dermatologic Therapy"
DOI: 10.1111/dth.13843
Abstract: Dear Editor, Granulomatous pigmented purpuric dermatosis (PPD) is a recently recognized, rare histological variant of PPD. In a retrospective study of 107 cases of PPD, granulomatous variant was observed in 4 (3.7%) patients. It is… read more here.
Keywords: granulomatous pigmented; pigmented purpuric; colchicine calcium; purpuric dermatosis ... See more keywords
Early glucocorticoid withdrawal in severe ANCA‐associated vasculitis treated with combination cyclophosphamide and rituximab: a single‐centre case series
Sign Up to like & getrecommendations! Published in 2025 at "Internal Medicine Journal"
DOI: 10.1111/imj.70212
Abstract: Glucocorticoid (GC)‐related toxicity remains a major challenge in anti‐neutrophil cytoplasm antibody‐associated vasculitis (AAV). We report five cases of newly diagnosed severe AAV treated with combination cyclophosphamide and rituximab, with the goal of ceasing GCs within… read more here.
Keywords: combination cyclophosphamide; associated vasculitis; cyclophosphamide rituximab; treated combination ... See more keywords